U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C17H19NO3.5H2O.H2O4S
Molecular Weight 758.83
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MORPHINE SULFATE

SMILES

O.O.O.O.O.OS(O)(=O)=O.[H][C@@]12OC3=C4C(C[C@H]5N(C)CC[C@@]14[C@@]5([H])C=C[C@@H]2O)=CC=C3O.[H][C@@]67OC8=C9C(C[C@H]%10N(C)CC[C@@]69[C@@]%10([H])C=C[C@@H]7O)=CC=C8O

InChI

InChIKey=GRVOTVYEFDAHCL-RTSZDRIGSA-N
InChI=1S/2C17H19NO3.H2O4S.5H2O/c2*1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18;1-5(2,3)4;;;;;/h2*2-5,10-11,13,16,19-20H,6-8H2,1H3;(H2,1,2,3,4);5*1H2/t2*10-,11+,13-,16-,17-;;;;;;/m00....../s1

HIDE SMILES / InChI
Molecular Formula H2O4S
Molecular Weight 98.078
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C17H19NO3
Molecular Weight 285.3377
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED
Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:32:13 UTC 2023
Edited
by admin
on Fri Dec 15 15:32:13 UTC 2023
Record UNII
X3P646A2J0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MORPHINE SULFATE
EP   MART.   ORANGE BOOK   USP   VANDF   WHO-IP  
Common Name English
Morphine sulfate pentahydrate [WHO-DD]
Common Name English
MORPHINE SULFATE CII [USP-RS]
Common Name English
KADIAN
Brand Name English
KAPANOL
Brand Name English
MORPHINE SULFATE HYDRATE [JAN]
Common Name English
DEPODUR
Brand Name English
MORPHINAN-3,6-DIOL, 7,8-DIDEHYDRO-4,5-EPOXY-17-METHYL- (5.ALPHA.,6.ALPHA.)-, SULFATE, HYDRATE (2:1:5)
Common Name English
MORPHINE SULFATE [EP MONOGRAPH]
Common Name English
MST CONTINUS
Brand Name English
DOLCONTIN
Brand Name English
ASTRAMORPH
Brand Name English
DURAMORPH
Brand Name English
7,8-DIDEHYDRO-4,5.ALPHA.-EPOXY-17-METHYLMORPHINAN-3,6.ALPHA.-DIOL SULPHATE (2:1) (SALT) PENTAHYDRATE
Common Name English
7,8-Didehydro-4,5α-epoxy-17-methylmorphinan-3,6α-diol sulfate (2:1) (salt) pentahydrate
Common Name English
MORPHINAN-3,6-DIOL, 7,8-DIDEHYDRO-4,5-EPOXY-17-METHYL, (5.ALPHA.,6.ALPHA.)-, SULFATE (2:1) (SALT), PENTAHYDRATE
Common Name English
MORPHINE SULPHATE PENTAHYDRATE
Common Name English
MORPHINE HEMISULFATE HEMIPENTAHYDRATE
Common Name English
AVINZA
Brand Name English
MSIR
Brand Name English
MORPHINE SULFATE [VANDF]
Common Name English
MORPHINE SULFATE PENTAHYDRATE [MI]
Common Name English
MORPHINI SULFAS [WHO-IP LATIN]
Common Name English
MORPHINAN-3,6-DIOL, 7,8-DIDEHYDRO-4,5-EPOXY-17-METHYL, (5.ALPHA.,6.ALPHA.)-, SULPHATE (2:1) (SALT), PENTAHYDRATE
Common Name English
MORPHINE SULFATE [MART.]
Common Name English
EMBEDA COMPONENT MORPHINE SULFATE
Common Name English
MORPHINE SULFATE HYDRATE
JAN  
Common Name English
MORPHINE SULFATE [ORANGE BOOK]
Common Name English
MORPHINE SULFATE CII
USP-RS  
Common Name English
MORPHINE SULFATE PENTAHYDRATE
MI   WHO-DD  
Common Name English
ARYMO
Brand Name English
ORAMORPH
Brand Name English
INFUMORPH
Brand Name English
MORPHINE SULFATE [USP MONOGRAPH]
Common Name English
MORPHINE SULPHATE
Common Name English
MORPHABOND
Brand Name English
MS CONTIN
Brand Name English
MOSCONTIN
Brand Name English
MORCAP
Brand Name English
MORPHINE SULFATE COMPONENT OF EMBEDA
Common Name English
SEVREDOL
Brand Name English
MORPHINE SULFATE [WHO-IP]
Common Name English
Classification Tree Code System Code
DEA NO. 9300
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
NCI_THESAURUS C67413
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
FDA ORPHAN DRUG 18587
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
Code System Code Type Description
EVMPD
SUB22187
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
FDA UNII
X3P646A2J0
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
PUBCHEM
6321225
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
SMS_ID
100000090222
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
NCI_THESAURUS
C669
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
EVMPD
SUB14597MIG
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
WIKIPEDIA
Morphine sulfate
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
DRUG BANK
DBSALT000122
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
MERCK INDEX
m7631
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY Merck Index
WHO INTERNATIONAL PHARMACOPEIA
MORPHINE SULFATE
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY Description: White, feathery needles of a white, crystalline powder or cubical masses; odourless. Solubility: Soluble in 20 parts of water; slightly soluble in ethanol (~750 g/l) TS; practically insoluble in ether R. Category: Analgesic. Storage: Morphine sulfate should be kept in a tightly closed container, protected from light. Additional information: Morphine sulfate loses water of hydration on exposure to air and darkens in colour on prolonged exposureto light. Definition: Morphine sulfate contains not less than 98.0% and not more than 101.0% of (C17H19NO3)2,H2SO4, calculated with reference to the dried substance.
CAS
6211-15-0
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
CHEBI
50731
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
RS_ITEM_NUM
1448005
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
RXCUI
30236
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY RxNorm
DAILYMED
X3P646A2J0
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
EPA CompTox
DTXSID1048914
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
ChEMBL
CHEMBL70
Created by admin on Fri Dec 15 15:32:13 UTC 2023 , Edited by admin on Fri Dec 15 15:32:13 UTC 2023
PRIMARY
Related Record Type Details
Structure of MORPHINE
PARENT -> SALT/SOLVATE
Structure of MORPHINE SULFATE ANHYDROUS
ANHYDROUS->SOLVATE
Structure of MORPHINE SULFATE ANHYDROUS
BASIS OF STRENGTH->SUBSTANCE
ASSAY (GC)
USP
Structure of MORPHINE SULFATE ANHYDROUS
BASIS OF STRENGTH->SUBSTANCE
ASSAY (TITRATION)
EP
Related Record Type Details
Structure of MORPHINONE
IMPURITY -> PARENT
For the calculation of contents, multiply the peak areas by 0.5
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of (17S)-7,8-DIDEHYDRO-4,5.ALPHA.-EPOXY-17-METHYLMORPHINAN-3,6.ALPHA.-DIOL 17-OXIDE
IMPURITY -> PARENT
RS [USP]
Structure of ORIPAVINE
IMPURITY -> PARENT
For the calculation of contents, multiply the peak areas by 0.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of (17S)-7,8-DIDEHYDRO-4,5.ALPHA.-EPOXY-17-METHYLMORPHINAN-3,6.ALPHA.-DIOL 17-OXIDE
IMPURITY -> PARENT
UNSPECIFIED
EP
Structure of PSEUDOMORPHINE
IMPURITY -> PARENT
For the calculation of contents, multiply the peak areas by 0.25
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of CODEINE ANHYDROUS
IMPURITY -> PARENT
UNSPECIFIED
EP
Structure of HYDROXYMORPHINE, (10S)-
IMPURITY -> PARENT
UNSPECIFIED
EP
Related Record Type Details
Structure of MORPHINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966